Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00543608
Recruitment Status : Terminated (Trial terminated due to financial resource limitations)
First Posted : October 15, 2007
Last Update Posted : February 13, 2009
Information provided by:
Arpida AG

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Estimated Primary Completion Date : April 2009
  Estimated Study Completion Date : May 2009